mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.093 |
0.1 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.085 |
0.1 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.2 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.2 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.2 |